Menopausal hormone therapy tied to lower risk for outcomes related to Alzheimer’s disease

Women who used estrogen-only menopausal hormonal therapy later in life had lower risks for neuropathologic and clinical outcomes related to Alzheimer’s disease, according to data published in Neurology. “As part of an NIH-funded study examining how aging interacts with Alzheimer’s disease, we were particularly interested in sex differences,” Hadi Hosseini, PhD, associate